Loading provider…
Loading provider…
General Practice Physician in Miramar, FL
NPI: 1386070159Primary Practice Location
Mdlive Medical Group TX PLLC
3350 SW 148th Ave, Miramar, FL
Primary Employer
Zion Urgent Care
zionurgentcare.com
HQ Phone
Get M.D. Tewodros's Phone Numberphone_androidMobile
Get M.D. Tewodros's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
CA State Medical License
CA State Medical License
2014 - 2026
TX State Medical License
2016 - 2026

American Board of Internal Medicine
Internal Medicine
Alameda Health System-Highland Hospital
Residency • Internal Medicine
2011 - 2014
Gondar College of Medical Sciences
Medical School
Until 1996
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 112 | 217 |
| 2 | 0241URespiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | 94 | 121 |
| 3 | 99203New patient outpatient visit, total time 30-44 minutes | 90 | 90 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 37 | 78 |
| 5 | 87880Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 33 | 34 |
Lead Sponsor: Eli Lilly and Company
Collaborators: AbCellera Biologics Inc., Shanghai Junshi Bioscience Co., Ltd.
Intervention / Treatment: DRUG: Placebo, DRUG: LY3819253, DRUG: LY3832479, DRUG: LY3853113
Lead Sponsor: Eli Lilly and Company
Collaborators: GlaxoSmithKline, AbCellera Biologics Inc., Shanghai Junshi Bioscience Co., Ltd., Vir Biotechnology, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Bebtelovimab, DRUG: Etesevimab, DRUG: Bamlanivimab, DRUG: VIR-7831